Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans.
暂无分享,去创建一个
N. Lundbom | A. Rissanen | K. Silander | Markku Peltonen | A. Hakkarainen | B. Fielding | V. Olkkonen | A. Kotronen | J. Makkonen | H. Yki-Järvinen | H. Gylling | K. Sevastianova | J. Lundbom | S. Romeo | A. Santos | Ksenia Sevastianova | Janne Makkonen
[1] Jonathan C. Cohen,et al. Expression and Characterization of a PNPLA3 Protein Isoform (I148M) Associated with Nonalcoholic Fatty Liver Disease* , 2011, The Journal of Biological Chemistry.
[2] N. Lundbom,et al. Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans. , 2011, The American journal of clinical nutrition.
[3] S. Sookoian,et al. Meta‐analysis of the influence of I148M variant of patatin‐like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease , 2011, Hepatology.
[4] F. Schick,et al. Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial , 2011, British Journal of Nutrition.
[5] M. Hellerstein,et al. A dual sugar challenge test for lipogenic sensitivity to dietary fructose. , 2011, The Journal of clinical endocrinology and metabolism.
[6] M. Orešič,et al. Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease. , 2010, Gastroenterology.
[7] G. Bray. Fructose: Pure, White, and Deadly? Fructose, by Any other Name, is a Health Hazard , 2010, Journal of diabetes science and technology.
[8] R. Kreis,et al. Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men. , 2010, Diabetes & metabolism.
[9] A. Suzuki,et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease , 2010, Hepatology.
[10] R. Kreis,et al. Effects of a short-term overfeeding with fructose or glucose in healthy young males. , 2010, The British journal of nutrition.
[11] Veikko Salomaa,et al. Thirty-five-year trends in cardiovascular risk factors in Finland. , 2010, International journal of epidemiology.
[12] L. Tappy,et al. Metabolic effects of fructose and the worldwide increase in obesity. , 2010, Physiological reviews.
[13] Nick V. Grishin,et al. A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis , 2009, The Journal of Biological Chemistry.
[14] S. Klein,et al. Diet and Exercise Interventions Reduce Intrahepatic Fat Content and Improve Insulin Sensitivity in Obese Older Adults , 2009, Obesity.
[15] N. Lundbom,et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. , 2009, Gastroenterology.
[16] J. Borén,et al. Lipid droplets as dynamic organelles connecting storage and efflux of lipids. , 2009, Biochimica et biophysica acta.
[17] R. Kreis,et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. , 2009, The American journal of clinical nutrition.
[18] D. Reeds,et al. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. , 2009, Gastroenterology.
[19] M. Ridderstråle,et al. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans , 2009, Diabetologia.
[20] M. Orešič,et al. Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver , 2009, Diabetes.
[21] F. Schick,et al. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease , 2008, Gut.
[22] Olli Saarela,et al. Gender Differences in Genetic Risk Profiles for Cardiovascular Disease , 2008, PloS one.
[23] S. Bischoff,et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. , 2008, The Journal of nutrition.
[24] E. Parks,et al. Dietary sugars stimulate fatty acid synthesis in adults. , 2008, The Journal of nutrition.
[25] S. McCall,et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. , 2008, Journal of hepatology.
[26] F. Karpe,et al. Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding. , 2008, The American journal of clinical nutrition.
[27] A. Kotronen,et al. Effect of liver fat on insulin clearance. , 2007, American journal of physiology. Endocrinology and metabolism.
[28] K. Pietiläinen,et al. Liver fat in the metabolic syndrome. , 2007, The Journal of clinical endocrinology and metabolism.
[29] E. Ravussin,et al. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. , 2006, The American journal of clinical nutrition.
[30] H. Conjeevaram,et al. Metabolic Syndrome Is Associated with Greater Histologic Severity, Higher Carbohydrate, and Lower Fat Diet in Patients with NAFLD , 2006, The American Journal of Gastroenterology.
[31] J. Dixon,et al. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging , 2006 .
[32] E. Ravussin,et al. Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. , 2006, Diabetes care.
[33] F. Schick,et al. Hepatic lipid accumulation in healthy subjects: A comparative study using spectral fat‐selective MRI and volume‐localized 1H‐MR spectroscopy , 2006, Magnetic resonance in medicine.
[34] A. Häkkinen,et al. Overproduction of large VLDL particles is driven by increased liver fat content in man , 2006, Diabetologia.
[35] J. Jessurun,et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.
[36] S. Grundy,et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. , 2005, American journal of physiology. Endocrinology and metabolism.
[37] E. Parks,et al. Temporal pattern of de novo lipogenesis in the postprandial state in healthy men. , 2005, The American journal of clinical nutrition.
[38] M. Alam,et al. Triacylglycerol hydrolase: role in intracellular lipid metabolism , 2004, Cellular and Molecular Life Sciences CMLS.
[39] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[40] M. Beylot,et al. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. , 2003, Diabetes & metabolism.
[41] Fredrik Karpe,et al. Selective partitioning of dietary fatty acids into the VLDL TG pool in the early postprandial period Published, JLR Papers in Press, August 16, 2003. DOI 10.1194/jlr.M300167-JLR200 , 2003, Journal of Lipid Research.
[42] D. Vance,et al. The FASEB Journal express article 10.1096/fj.02-0728fje. Published online July 18, 2003. Inhibitors of hepatic microsomal triacylglycerol hydrolase decrease very low density lipoprotein secretion , 2022 .
[43] R. Mensink,et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. , 2003, The American journal of clinical nutrition.
[44] S. Wootton,et al. Regulation of dietary fatty acid entrapment in subcutaneous adipose tissue and skeletal muscle. , 2002, Diabetes.
[45] A. Häkkinen,et al. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. , 2000, Diabetes.
[46] R. Wolfe,et al. Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men. , 1998, Journal of lipid research.
[47] J Hirsch,et al. Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet. , 1996, The Journal of clinical investigation.
[48] C. Thomsen,et al. Quantification of liver fat using magnetic resonance spectroscopy. , 1994, Magnetic resonance imaging.
[49] Korchak Hm. Regulation of hepatic lipogenesis. , 1962 .
[50] R. Havel,et al. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.